Samuel R. Saks

2009

In 2009, Samuel R. Saks earned a total compensation of $331.2K as Former Chief Executive Officer at Jazz Pharmaceuticals, a 66% decrease compared to previous year.

Compensation breakdown

Option Awards$189,260
Salary$141,392
Other$520
Total$331,172

Saks received $189.3K in option awards, accounting for 57% of the total pay in 2009.

Saks also received $141.4K in salary and $520 in other compensation.

Rankings

In 2009, Samuel R. Saks' compensation ranked 8,106th out of 9,885 executives tracked by ExecPay. In other words, Saks earned more than 18.0% of executives.

ClassificationRankingPercentile
All
8,106
out of 9,885
18th
Division
Manufacturing
3,046
out of 3,690
18th
Major group
Chemicals And Allied Products
703
out of 866
19th
Industry group
Drugs
506
out of 638
21st
Industry
Pharmaceutical Preparations
371
out of 446
17th
Source: SEC filing on April 16, 2010.

Saks' colleagues

We found four more compensation records of executives who worked with Samuel R. Saks at Jazz Pharmaceuticals in 2009.

2009

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2009

Robert Myers

Jazz Pharmaceuticals

President

2009

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2009

Carol Gamble

Jazz Pharmaceuticals

General Counsel

In-depth

You may also like